Guided Therapeutics (GTHP) Change in Account Payables (2011 - 2021)
Guided Therapeutics' (GTHP) quarterly Change in Account Payables came in at -$84000.0 in Q2 2021, down 197.67% year-on-year from $86000.0 in Q2 2020, and down 389.66% quarter-over-quarter from $29000.0 in Q1 2021.
Guided Therapeutics (GTHP) Change in Account Payables (2011 - 2021) Analysis & Trends
Guided Therapeutics has disclosed Change in Account Payables across 11 years of filings, most recently posting -$84000.0 for Q2 2021.
- Change in Account Payables for Q2 2021 came in at -$84000.0, down 197.67% year-over-year; the trailing twelve-month figure through Jun 2021 was -$446000.0 (down 4560.0% YoY), and the FY2020 annual result was -$372000.0, down 1960.0% from the prior year.
- Change in Account Payables came in at -$84000.0 for Q2 2021 at Guided Therapeutics, down from $29000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $148000.0 in Q1 2017 to a low of -$208000.0 in Q3 2020.
- The 5-year median for Change in Account Payables is $20500.0 (2018), against an average of $388.89.
- Across the five-year window, Change in Account Payables jumped 353.33% in 2019 and tumbled 730.3% in 2020, its largest moves.
- Guided Therapeutics' Change in Account Payables stood at $54000.0 in 2017, then fell by 22.22% to $42000.0 in 2018, then slumped by 200.0% to -$42000.0 in 2019, then sank by 335.71% to -$183000.0 in 2020, then jumped by 54.1% to -$84000.0 in 2021.
- The last three Change in Account Payables figures came in at -$84000.0 (Q2 2021), $29000.0 (Q1 2021), and -$183000.0 (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 221.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -84,000.00 |
| Jun 30, 2021 | -84,000.00 |
| Mar 31, 2021 | 29,000.00 |
| Mar 31, 2021 | 29,000.00 |
| Dec 31, 2020 | -183,000.00 |
| Dec 31, 2020 | -183,000.00 |
| Sep 30, 2020 | -208,000.00 |
| Sep 30, 2020 | -208,000.00 |
| Jun 30, 2020 | 86,000.00 |
| Jun 30, 2020 | 86,000.00 |
| Mar 31, 2020 | -67,000.00 |
| Mar 31, 2020 | -67,000.00 |
| Dec 31, 2019 | -42,000.00 |
| Dec 31, 2019 | -42,000.00 |
| Sep 30, 2019 | 33,000.00 |
| Sep 30, 2019 | 33,000.00 |
| Jun 30, 2019 | 38,000.00 |
| Jun 30, 2019 | 38,000.00 |
| Mar 31, 2019 | -9,000.00 |
| Mar 31, 2019 | -9,000.00 |